Cancer, the very name alone scares most people. These days man has a vast amount of information on what things cause the disease, how it progresses, it's growth rates vs. age, which forms are faster spreading than others but what we don't posses is the answer as to how to stop it. I won't touch on what I believe are the business reasons why the disease has such poor treatment rates in the US as opposed to else where, this isn't the forum for it. Suffice to say that other countries have a better handle on fighting the disease than we do and lets look at one of the reasons why. Neoplasm's (cancers) are smart and cagey buggers. They can hide and grow for a good spell undetected, they don't need oxygen to live (at least 99.9% of them don't), and while you can kill most all of it with special treatments and surgery all it take's is for one cell to survive to have the condition grow back again. Many cancers are hormonally driven, such as testicular cancer in younger men or cancers of the reproductive organs in middle aged and older women.
This provides the perfect fuel as during those periods of life certain hormones abound. A cancer is built to survive. CA (cancer) cells are covered with fibrin (the same stuff scar tissue is made of). Then as the cells glom together to form tumors these growths themselves are armored with fibrin. This thick protective coating is designed to prevent the bodies' own defenses (i.e. Natural Killer cells, White blood cells or Oxygen) from getting inside the cell or tumor and destroy it. It is this same defense that keeps chemotherapy out of the cells in all but industrial strength doses. (Doses that are just as likely to kill the patient as the cancer). It is this same defense that keeps out whatever natural agent's patients may be using to combat the disease. Would it not make sense to have something strip away the outer fibrous wall of CA so that whatever agents we are using as medicine, whether natural or otherwise, can actually get into the cell and do their job? Sure as heck does? That idea has made sense in Europe and Asia for almost 30 years.
There docs have been throwing highly fibrinolytic enzymes (scar tissue eating enzymes) both in blends and as solo enzymes at cancers outer coating and getting better results with turning the tide that the folks here in the States. So why has something with a 30 year history of proven worth and clinical application not reached the shores of America yet? Good question. In truth, there have been attempts to introduce systemic enzymes into cancer therapy here as far back as the 1970's. Dr. William Kelly DDS, had an enzyme based anti cancer therapy he used on pancreatic cancer patients. For those not familiar with that form of cancer the survival rate from it was 0. Dr. Kelly had a record of remission with his patients of 80+%. (1). Not possible thought the ivory towers of establishment medicine. Also two major hindrances kept popping up for Dr. Kelly, first he was a dentist not an MD. Secondly it was also not believed here in this country that enzymes could be absorbed orally. That kept many a doc from even looking at Kelly's findings. (2,3).
So they sent a young medical intern, Dr. Nicholas Gonzalez to investigate Kelly's claims and debunk him. Far from proving him a fraud the young MD found Kelly's treatments worked and his recovery rate was as he said. That did not settle things. The story of Dr. Kelly's persecution, the mysterious death of his wife and his being run out of the country is too long a tale to take up here. Nuff said that his therapy worked. Concurrent with those events, in Germany and Japan enzymes were being used both singly and in groups by orthodox medical researchers to augment established therapy. It was found that by introducing a strongly fibrinolytic enzyme like chymo trypsin or serrapeptase that anti cancer medications penetrated the cancer cell easier. Therefore lower dosages of chemotherapy could be used and high levels of toxicity in the patient could be avoided. Along with that researchers found that the enzymes seemed to reduce the side effects of the chemotherapy and, definitely reduced the debilitating muscle wasting that chemo therapy produced in it's patients. (4,5,6)
In radiation therapy patients, these doctors found that taking systemic enzymes after treatments reduced the fibrosis that grew in the treated organs. Organs treated with radiation become very hard filled with scar tissue, which restricts the organ and reduces its overall function. The enzymes were found to prevent a good bit of that scaring from occurring and where it had already happened, the enzymes reduced existing fibrosis. (7). The use of orally administered systemic enzymes to aid in the treatment of cancer was embraced by these countries. After decades of resistance systemic enzyme therapy as an adjunct to overall cancer treatment has finally gained a foothold in America. Holistic and alternative cancer treatment centers are using enzymes to assist in the fight against the disease. Individual oncologists, realizing the clinical advantage posed by these agents, are now introducing them into the toolbox of things one can do against the disease.
No less than the likes of the great Naturopathic physician Dr. Michael Murray recommends systemic enzyme use in his work "How to Prevent and Treat Cancer With Natural Medicine". Now here's the pitch: a serrapeptase based enzyme blend that is super highly fibrinolytic (fibrin / scar tissue eating). To quote from Dr. Murray: "Serratia peptidase exerts more powerful effects than chymotrypsin and trypsin in all of these applications". Serratia peptidase is the same as serrapeptase. Remembering that enzymes in blends exert a far greater range and strength of actions than solo enzymes and remembering that serrapeptase is the "activating" enzyme in systemic enzyme blends, I believe that systemic blends are best to apply in the fight against cancer. Nuff Said.
- Dr. William Kelly's' book "One Answer to Cancer" is available free as a download on: http://www.drkelley.com/CANLIVER55.html
- Moriya, N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, Kakinuma A. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem. 1994; 20(Pt1):101-8.
- Miyata, K. Intestinal absorption of Serratia Peptidase. J Appl Biochem. 1980;2:111-16.
- Rosanova, A.: The present stand of enzyme therapy in the treatment of malignant tumors. Arztl Praxis XVI 36, 1964, 1442-1444.
- Konig, W.: Enzyme therapy in the treatment of viral diseases and carcinoma. Erfahrungsheilk. 38, 1989, 455-459.
- Desser, L., Ransberger, A.: Introduction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes. Oncology 47, 1990, 475.
- Beaufort, E.: Reduction in the adverse effects of radiation therapy with hydrolytic enzymes. Therapeutikon 10, 1990, 577-580.